1887

Abstract

The majority of neutralizing monoclonal antibodies (MAbs) to the haemagglutinin-neuraminidase (HN) glycoprotein of Newcastle disease virus prevent attachment of the virus to cellular receptors and inhibits virion-induced fusion from without (FFWO) and fusion from within (FFWI) mediated by the virus glycoprotein-laden infected cell surface. For these antibodies, the inhibition of fusion is presumed to be the result of the prevention of HN-mediated bridging of potential fusion partners. MAbs against antigenic sites 3 and 4 neutralize virus infectivity, but by a mechanism other than the prevention of attachment, the exact nature of which remains to be established. Antibodies to both of these sites effectively inhibit virion-induced FFWO, even when the inducing virus is not infectious. This is consistent with the mechanism of neutralization of these MAbs involving the inhibition of an early, post-attachment step in infection. MAbs to site 3 also inhibit FFWI, but those to site 4 do not, even when added at high concentrations. This suggests that the requirement for HN may be different in the two modes of fusion. The epitopes recognized by MAbs to sites 3 and 4 have been delineated by the identification of individual nucleotide substitutions in the HN genes of neutralization escape variants. Some of the deduced amino acid substitutions result in additional -linked glycosylation sites in HN, which are utilized and presumably account for the escape from neutralization.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-5-1167
1992-05-01
2022-08-11
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/5/JV0730051167.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-5-1167&mimeType=html&fmt=ahah

References

  1. Alkhatib G., Richardson C., Shen S. H. 1990; Intracellular processing, glycosylation, and cell-surface expression of the measles virus fusion protein (F) encoded by a recombinant adenovirus. Virology 175:262–270
    [Google Scholar]
  2. Bratt M. A., Gallaher W. R. 1969; Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus (NDV). Proceedings of the National Academy of Sciences, U.S.A. 64:536–543
    [Google Scholar]
  3. Bratt M. A., Gallaher W. R. 1972; Biological parameters of fusion from within and fusion from without. In Membrane Research pp 383–406 Edited by Fox C. F. New York: Academic Press;
    [Google Scholar]
  4. Citovsky V., Yanai P., Loyter A. 1986; The use of circular dichroism to study conformational changes induced in Sendai virus envelope glycoprotein. Journal of Biological Chemistry 261:2235–2239
    [Google Scholar]
  5. Clavell L. A., Bratt M. A. 1972; Hemolytic interaction of Newcastle disease virus and chicken erythrocytes. II. Determining factors. Applied Microbiology 23:461–470
    [Google Scholar]
  6. Davis D., Stephens D. M., Willers C., Lachmann P. J. 1990; Glycosylation governs the binding of antipeptide antibodies to regions of hypervariable amino acid sequence within recombinant gp120 of human immunodeficiency virus type 1. Journal of General Virology 71:2889–2898
    [Google Scholar]
  7. Davis N. L., Pence D. F., Meyer W. J., Schmaljohn A. L., Johnston R. E. 1987; Alternative forms of a strain-specific neutralizing antigenic site on the Sindbis virus E2 glycoprotein. Virology 161:101–108
    [Google Scholar]
  8. DeVries P., van Binnendijk R. S., van der Marel P., Beuvery E. C., van Wezel A. L., Voorma H. O., UytdeHaag F. G. C. M., Osterhaus A. D. M. E. 1987; Inhibition of measles virus-induced cell-cell fusion with a monoclonal antibody directed against the haemagglutinin. Viral Immunology 1:25–34
    [Google Scholar]
  9. Ebata S. N., Cote M.-J., Kang C. Y., Dimock K. 1991; The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion. Virology 183:437–441
    [Google Scholar]
  10. Gitman A. G., Loyter A. 1984; Construction of fusogenic vesicles bearing specific antibodies. Targeting of reconstituted Sendai virus envelopes towards neuraminidase-treated human erythrocytes. Journal of Biological Chemistry 259:9813–9820
    [Google Scholar]
  11. Gotoh B., Sakaguchi T., Nishikawa K., Inocencio N. M., Hamaguchi M., Toyoda T., Nagai Y. 1988; Structural features unique to each of the three antigenic sites on the hemagglutininneuraminidase protein of Newcastle disease virus. Virology 163:174–182
    [Google Scholar]
  12. Hightower L. E., Morrison T. G., Bratt M. A. 1975; Relationships among the polypeptides of Newcastle disease virus. Journal of Virology 16:1599–1607
    [Google Scholar]
  13. Iorio R. M., Bratt M. A. 1983; Monoclonal antibodies to Newcastle disease virus: delineation of four epitopes on the HN glycoprotein. Journal of Virology 48:440–450
    [Google Scholar]
  14. Iorio R. M., Bratt M. A. 1984; Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sites. Journal of Immunology 133:2215–2219
    [Google Scholar]
  15. Iorio R. M., Bratt M. A. 1985; Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin. Proceedings of the National Academy of Sciences, U.S.A. 82:7106–7110
    [Google Scholar]
  16. Iorio R. M., Lawton K. A., Nicholson P. M., Bratt M. A. 1984; Monoclonal antibodies identify a strain-specific epitope on the HN glycoprotein of Newcastle disease virus strain Australia-Victoria. Virus Research 1:513–525
    [Google Scholar]
  17. Iorio R. M., Borgman J. B., Glickman R. L., Bratt M. A. 1986; Genetic variation within a neutralizing domain on the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. Journal of General Virology 67:1393–1403
    [Google Scholar]
  18. Iorio R. M., Glickman R. L., Riel A. M., Sheehan J. P., Bratt M. A. 1989a; Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment. Virus Research 13:245–262
    [Google Scholar]
  19. Iorio R. M., Syddall R. J., Glickman R. L., Riel A. M., Sheehan J. P., Bratt M. A. 1989b; Identification of amino acid residues important to the neuraminidase activity of the HN glycoprotein of Newcastle disease virus. Virology 173:196–204
    [Google Scholar]
  20. Iorio R. M., Syddall R. J., Sheehan J. P., Bratt M. A., Glickman R. L., Riel A. M. 1991; Neutralization map of the HN glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition. Journal of Virology 65:4999–5006
    [Google Scholar]
  21. Kornfeld R., Kornfeld S. 1985; Assembly of asparagine-linked oligosaccharides. Annual Review of Biochemistry 54:631–664
    [Google Scholar]
  22. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
  23. McGinnes L. W., Wilde A., Morrison T. G. 1987; Nucleotide sequence of the gene encoding the Newcastle disease virus hemagglutinin-neuraminidase protein and comparisons of paramyxovirus hemagglutinin-neuraminidase protein sequences. Virus Research 7:187–202
    [Google Scholar]
  24. Markwell M. A. K., Portner A., Schwartz A. L. 1987; An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein. Proceedings of the National Academy of Sciences, U.S.A. 82:978–982
    [Google Scholar]
  25. Miura N., Uchida T., Okada Y. 1982; HVJ (Sendai virus)-induced envelope fusion and cell fusion are blocked by monoclonal anti-HN protein antibody that does not inhibit hemagglutination activity of HVJ. Experimental Cell Research 141:409–420
    [Google Scholar]
  26. Morrison T. G., McQuain C., McGinnes L. 1991; Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion. Journal of Virology 65:813–822
    [Google Scholar]
  27. Moscona A., Peluso R. W. 1991; Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion. Journal of Virology 65:2772–2777
    [Google Scholar]
  28. Nakanishi M., Uchida T., Kim J., Okada Y. 1982; Glycoproteins of Sendai virus (HVJ) have a critical ratio for fusion between virus envelopes and cell membranes. Experimental Cell Research 142:95–101
    [Google Scholar]
  29. Olmstead R. A., Elango N., Prince G. A., Murphy B. R., Johnson P. R., Moss B., Chanock R. M., Collins P. L. 1986; Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proceedings of the National Academy of Sciences, U.S.A. 83:7462–7466
    [Google Scholar]
  30. Paterson R. G., Hiebert S. W., Lamb R. A. 1985; Expression at the cell surface of biologically active fusion and hemagglutinin/ neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proceedings of the National Academy of Sciences, U.S.A. 82:7520–7524
    [Google Scholar]
  31. Peeples M. E., Bratt M. A. 1984; Mutation in the matrix protein of Newcastle disease virus can result in decreased fusion glycoprotein incorporation into particles and decreased infectivity. Journal of Virology 51:81–90
    [Google Scholar]
  32. Sakaguchi T., Toyoda T., Gotoh B., Inocencio N. M., Kuma K., Miyata T., Nagai Y. 1989; Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene. Virology 169:260–272
    [Google Scholar]
  33. Sakai Y., Shibuta H. 1989; Syncytium formation by recombinant vaccinia viruses carrying bovine parainfluenza 3 virus envelope protein genes. Journal of Virology 63:3661–3668
    [Google Scholar]
  34. Scheid A., Choppin P. W. 1973; Isolation and purification of the envelope proteins of Newcastle disease virus. Journal of Virology 11:263–271
    [Google Scholar]
  35. Schuy W., Garten W., Linder D., Klenk H. -D. 1984; The carboxy terminus of the hemagglutinin-neuraminidase of Newcastle disease virus is exposed at the surface of the viral envelope. Virus Research 1:415–426
    [Google Scholar]
  36. Sheehan J. P., Iorio R. M., Syddall R. J., Glickman R. L., Bratt M. A. 1987; Reducing agent-sensitive dimerization of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus correlates with the presence of cysteine at residue 123. Virology 161:603–606
    [Google Scholar]
  37. Skehel J. J., Stevens D. J., Daniels R. S., Douglas A. R., Knossow M., Wilson I. A., Wiley D. C. 1984; A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proceedings of the National Academy of Sciences, U.S.A. 81:1779–1783
    [Google Scholar]
  38. Tsurudome M., Yamada A., Hishiyama M., Ito Y. 1986; Monoclonal antibodies against the glycoproteins of mumps virus: fusion inhibition by anti-HN monoclonal antibody. Journal of General Virology 67:2259–2265
    [Google Scholar]
  39. Weiss S. R., Bratt M. A. 1974; Polyadenylate sequences on Newcastle disease virus mRNA synthesized in vivo and in vitro. Journal of Virology 13:1220–1230
    [Google Scholar]
  40. Yusoff K., Nesbit M., Samson A. C. R., Emmerson P. T. 1989; Effect of amino acid substitutions on glycosylation of the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus strain Beaudette C. Journal of General Virology 70:1549–1552
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-5-1167
Loading
/content/journal/jgv/10.1099/0022-1317-73-5-1167
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error